Dan Hicklin

Daniel J.
Hicklin is the founder of Potenza Therapeutics, Inc., founded in 2014, where the title held was President, Chief Executive Officer & Director from 2014 to 2018.
Dr. Hicklin is the founder of Werewolf Therapeutics, Inc., founded in 2017, holding the titles of President, Chief Executive Officer & Director since 2019.
Dr. Hicklin currently holds the position of Director at Maverick Therapeutics, Inc. Former positions include President & Chief Executive Officer at Trieza Therapeutics, Inc., Managing Director at MPM BioImpact LLC, Director at Tizona Therapeutics, Inc., Vice President at ImClone LLC from 1987 to 2006, Assistant Professor at New York Medical College, Principal at Merck Research Laboratories Massachusetts LLC in 2013, and President & Chief Scientific Officer at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Iowa and graduate and doctorate degrees from New York Medical College.